Theory 09/Pain & Somatosensation /Pain neuroscience/3 min
Relief and Chronification Share a Circuit
Why some people recover and others do not may be the same question as why some respond to a sugar pill.
Placebo analgesia and the transition to chronic pain are opposite directions along the same effective-connectivity axis, so an individual's placebo response should predict their risk of chronification, and the two should not be independent traits.
01The evidence
- Effective connectivity studies of nociception have examined chronic pain and placebo response within a common predictive-coding framework, which places them on one axis rather than in separate literatures.Journal of Neuroscience, 2025
- Chronic pain has been modelled as a maladaptive compensation to unbalanced hierarchical predictive processing, a formulation that makes the direction of the imbalance the key variable.NeuroImage
02The tension
Placebo response is studied as a treatment effect, and chronification is studied as a disease process. They are investigated by different groups with different methods, and the possibility that they are the same mechanism read in opposite directions is rarely tested.
03The theory
Both phenomena involve the weighting of prior expectation against ascending nociceptive evidence. In placebo, the prior is strengthened and relief follows. In chronification, the prior becomes resistant to correction and pain persists despite healing.
If both are movements along one axis of precision weighting, then an individual's position on that axis should predict both. A person whose priors dominate should be a strong placebo responder and also at higher risk of chronification after injury, because the same dominance produces both outcomes.
The prediction is a correlation between placebo response magnitude and chronification risk in prospective cohorts. That is a striking claim because it means a beneficial response and a harmful one share a cause, and it explains why placebo responders are not simply healthier.
The clinical consequence is that placebo responsiveness could serve as a risk stratifier, and that interventions which increase precision of sensory evidence could reduce chronification without blocking pain.
04What this is not
Placebo is treated as a positive expectancy effect and chronification as a maladaptive plasticity. This treats them as one axis, which predicts a correlation that neither literature looks for.
05Predictions
- P1Placebo analgesia magnitude should predict chronification risk in prospective cohorts.
- P2The two should load on a single connectivity axis rather than two.
- P3Interventions that increase sensory precision should reduce both placebo response and chronification.
06What would refute it
No correlation between placebo response and chronification, in a well-powered prospective study, would separate the mechanisms.
07What it would change
It would turn placebo response into a risk marker, and unify two research programmes.
08Evidence base
- Functional anatomy of nociception: connectivity in chronic pain and placebo — J Neuroscihttps://www.jneurosci.org/content/45/25/e1447242025
- Chronic pain as maladaptive compensation in hierarchical predictive processing — NeuroImagehttps://www.sciencedirect.com/science/article/pii/S1053811924002052